| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/22/2004 | CA2501870A1 Single chain recombinant t cell receptors |
| 04/22/2004 | CA2501851A1 Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 04/22/2004 | CA2501752A1 Compositions, organisms and methodologies employing a novel human kinase |
| 04/22/2004 | CA2501633A1 Recombinant adenoviral vectors and applications thereof |
| 04/22/2004 | CA2501630A1 Stem cell expansion factor blocking a gene limiting hox-induced expansion and method using such factor |
| 04/22/2004 | CA2501574A1 Process for the biological production of 1,3-propanediol with high yield |
| 04/22/2004 | CA2501476A1 Hiv vaccine formulations |
| 04/22/2004 | CA2501459A1 Production of homotrimeric fusion proteins |
| 04/22/2004 | CA2501445A1 Polypeptides involved in spiramycin biosynthesis, nucleotide sequences encoding said polypeptides and uses thereof |
| 04/22/2004 | CA2501308A1 Extraction of dna from biological samples |
| 04/22/2004 | CA2501289A1 Novel full-length genomic rna of japanese encephalitis virus, infectious jev cdna therefrom, and use thereof |
| 04/22/2004 | CA2501208A1 Decomposition and modification of silicate and silicone by silase and use of the reversible enzyme |
| 04/22/2004 | CA2501078A1 A transgenic animal comprising a gene operably linked to a cell cycle activated promoter |
| 04/22/2004 | CA2500757A1 A method for screening for an antimicrobial polypeptide |
| 04/22/2004 | CA2500741A1 Glucose transport mutants for production of biomaterial |
| 04/22/2004 | CA2500603A1 Gene expression profiling from ffpe samples |
| 04/22/2004 | CA2499324A1 S-adenosyl methionine decarboxylase inhibition for the treatment of a herpes simplex virus infection |
| 04/22/2004 | CA2499081A1 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment |
| 04/22/2004 | CA2498951A1 Method for enriching procaryotic dna |
| 04/22/2004 | CA2498918A1 Stabilized naked dna compositions |
| 04/22/2004 | CA2487854A1 Method for screening an agent for treating renal failure |
| 04/22/2004 | CA2465860A1 Methods and compositions for therapeutic use of rna interference |
| 04/21/2004 | EP1411131A1 Process for producing template dna and process for producing protein in cell-free protein synthesis system with the use of the same |
| 04/21/2004 | EP1411128A1 Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars |
| 04/21/2004 | EP1411127A1 Transgenic zoysiagrass with reduced shade avoidance |
| 04/21/2004 | EP1411126A1 Nitrilase and encoding polynucleotide |
| 04/21/2004 | EP1411125A1 Materials and methods for the alteration of enzyme and acetyl CoA levels in plants |
| 04/21/2004 | EP1411124A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 04/21/2004 | EP1411122A1 Method for the manufacture of nucleic acid molecules |
| 04/21/2004 | EP1411121A1 Dna fragments containing gene having function relating to autonomous proliferation of plasmid |
| 04/21/2004 | EP1411119A1 Process for constructing mutant |
| 04/21/2004 | EP1411118A1 CELL PROLIFERATION INHIBITORS CONTAINING ANTI−GLYPICAN 3 ANTIBODY |
| 04/21/2004 | EP1411116A1 PEPTIDE SYNTHASE GENE, PEPTIDE SYNTHASE AND PROCESS FOR PRODUCING DIPEPTIDE |
| 04/21/2004 | EP1411064A2 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours |
| 04/21/2004 | EP1411063A1 Peptide nucleic acids |
| 04/21/2004 | EP1411062A1 Process for producing dipeptide,peptide synthase to be used therein and process for producing peptide synthase |
| 04/21/2004 | EP1411061A1 Poly-alpha2,8-sialic acid mimetic peptides and their application |
| 04/21/2004 | EP1411060A1 PROCESS FOR PRODUCING DIPEPTIDE, L−AMINO ACID AMIDE HYDROLASE TO BE USED THEREIN AND PROCESS FOR PRODUCING L−AMINO ACID AMIDE HYDROLASE |
| 04/21/2004 | EP1410807A1 Methods and compositions useful for inhibition of angiogenesis |
| 04/21/2004 | EP1410802A1 Cell death inducers for mast cells |
| 04/21/2004 | EP1410304A2 Method for epigenetic feature selection |
| 04/21/2004 | EP1410301A2 System for identifying and analyzing expression of are-containing genes |
| 04/21/2004 | EP1410040A2 Method for identifying substances which modulate interleukin 4 (il-4) signaling |
| 04/21/2004 | EP1410038A2 Assays for identifying modulators of rhomboid polypeptides |
| 04/21/2004 | EP1410035A2 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
| 04/21/2004 | EP1410031A2 Methods of preparing multicolor quantum dot tagged beads and conjugates thereof |
| 04/21/2004 | EP1410030A1 Biosensor and method for detecting analytes by means of time-resolved luminescence |
| 04/21/2004 | EP1410023A2 Methods using o?6 -alkylguanine-dna alkyltransferases |
| 04/21/2004 | EP1410021A2 Aptamer-mediated regulation of gene expression |
| 04/21/2004 | EP1410019A1 Cardiovascular safety assay |
| 04/21/2004 | EP1410018A1 Method for detecting modultators of notch signalling |
| 04/21/2004 | EP1410017A2 Gap junction permeability assay |
| 04/21/2004 | EP1410011A2 Diagnosis and prognosis of breast cancer patients |
| 04/21/2004 | EP1409748A2 Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
| 04/21/2004 | EP1409743A1 Method and support for biological analysis using oligonucleotides comprising a marker capable of enzymatic activation |
| 04/21/2004 | EP1409741A1 Detection method of nucleic acid hybridization |
| 04/21/2004 | EP1409740A2 Asthma-associated gene |
| 04/21/2004 | EP1409739A2 High throughput assay system |
| 04/21/2004 | EP1409737A2 Methods for detecting and treating the early onset of aging-related conditions |
| 04/21/2004 | EP1409735A1 Dual resonance energy transfer nucleic acid probes |
| 04/21/2004 | EP1409732A2 Amplification of nucleic acid fragments using nicking agents |
| 04/21/2004 | EP1409731A2 Methods of modulating pharmacokinetics of oligonucleotides |
| 04/21/2004 | EP1409730A2 Virus detection method, primers therefor and screening kit |
| 04/21/2004 | EP1409729A2 Real happy mapping |
| 04/21/2004 | EP1409727A2 Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells |
| 04/21/2004 | EP1409724A2 Oligonucleotide probes used to detect parodontopathogenic bacteria by i in situ /i hybridization |
| 04/21/2004 | EP1409723A2 Method of determining dihydropyrimidine dehydrogenase gene expression |
| 04/21/2004 | EP1409720A2 In vitro selection of signaling aptamers |
| 04/21/2004 | EP1409716A1 Scoring system for the prediction of cancer recurrence |
| 04/21/2004 | EP1409715A2 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 04/21/2004 | EP1409713A1 ASSAY FOR MEASURING FACTOR VIIa-ANTITHROMBIN COMPLEXES |
| 04/21/2004 | EP1409711A2 Compositions and methods for increasing amino acid absorption in mammals |
| 04/21/2004 | EP1409710A1 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 04/21/2004 | EP1409709A2 A method for improving recombinant protein stability and solubility |
| 04/21/2004 | EP1409708A2 Glucans and glucansucrases derived from lactic acid bacteria |
| 04/21/2004 | EP1409702A1 Improved rect or recet cloning and subcloning method |
| 04/21/2004 | EP1409701A2 Fluorescently labelled locked nucleic acids |
| 04/21/2004 | EP1409700A2 System for producing clonal or complex populations of recombinant adenoviruses, and the application of the same |
| 04/21/2004 | EP1409699A1 Recombinant vectors derived from adeno-associated virus expressing tam67 for gene therapy |
| 04/21/2004 | EP1409698A2 Ires enabled gene trapping in plants |
| 04/21/2004 | EP1409697A1 Expression cassettes for the transgenic expression of nucleic acids |
| 04/21/2004 | EP1409696A2 Identification and characterization of plant genes |
| 04/21/2004 | EP1409695A2 Expression system for recombinant proteins |
| 04/21/2004 | EP1409694A1 Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof |
| 04/21/2004 | EP1409693A2 Method for transformation of agaricus bisporus |
| 04/21/2004 | EP1409692A1 Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine |
| 04/21/2004 | EP1409691A2 Stereoselective preparation of cyclic l-amino acids |
| 04/21/2004 | EP1409690A2 Human endothelin converting enzyme-like proteins and polynucleotides encoding the same |
| 04/21/2004 | EP1409689A2 A lactococcus gene, the amylolytic enzyme it encodes and its application |
| 04/21/2004 | EP1409688A2 Nucleic acid sequences encoding enantioselective amidases |
| 04/21/2004 | EP1409687A2 22244 and 8701, human dehydrogenases and uses thereof |
| 04/21/2004 | EP1409686A2 Genes and proteins for the biosynthesis of rosaramicin |
| 04/21/2004 | EP1409684A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 04/21/2004 | EP1409683A2 i HELICOBACTER /i PROTEINS, NUCLEIC ACIDS AND USES THEREOF |
| 04/21/2004 | EP1409682A2 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes |
| 04/21/2004 | EP1409681A2 Proteins and nucleic acids encoding same |
| 04/21/2004 | EP1409680A2 Novel human proton-gated channels |
| 04/21/2004 | EP1409679A2 Nov-x proteins and nucleic acids encoding same |
| 04/21/2004 | EP1409678A2 Zis-sr nucleic acid and amino acid sequences involved in the regulated secretory pathway and/or the regulation of the neuroendocrine phenotype (nep) |
| 04/21/2004 | EP1409677A2 Receptors and membrane-associated proteins |